Discovery and preclinical evaluation of novel dopamine partial agonists as antipsychotic agents

Advances in Medicinal Chemistry

Volumn 5, Issue C, 2000, Pages 115-158

  Wustrow, David J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957021924     PISSN: 10675698     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1067-5698(00)80005-X     Document Type: Article

References (89)

1. Seeman P. Synapse 1 (1987) 133-152
2. Carlsson A., Hansson L.O., Waters N., and Carlsson M.L. Life Sci. (Washington, DC) 61 (1997) 75-94
3. Farde L. Schizophr. Res. 28 (1997) 157-162
4. Ackenheil M., and Hippius H. Psychopharmacology (N.Y.) 2 (1977) 923-956
5. Schmutz J., and Eichenberger E. Chron. Drug Discovery 1 (1982) 39-59
6. Leysen J.E., Gommeren W., Eens A., de Chaffoy de Courcelles D., Stoof J.C., and Janssen P.A. J. Pharmacol. Exp. Ther. 247 (1988) 661-670
7. Skarsfeldt T., and Perregaard J. Eur. J. Pharmacol. 182 (1990) 613-614
8. Fulton B., and Goa K.L. Drugs 53 (1997) 281-298
9. Bever K.A., and Perry P.J. Am. J. Health Syst. Pharm. 55 (1998) 1003-1016
10. Barnes T.R., and McPhillips M.A. Int. Clin. Psychopharmacol. 13 Suppl 3 (1998) S49-S57
11. Raja M. Drug Saf. 19 (1998) 57-72
12. Umbricht D., and Kane J.M. Schizophr. Bull. 22 (1996) 475-483
13. Jauss M., Schroder J., Pantel J., Bachmann S., Gerdsen I., and Mundt C. Pharmacopsychiatry 31 (1998) 146-148
14. Owens D.G. Drugs 51 (1996) 895-930
15. Willner P. Int. Clin. Psychopharmacol. 12 (1997) 297-308
16. Sibley D.R., and Monsma Jr. F.J. Trends Pharmacol. Sci. 13 (1992) 61-69
17. O'Dowd B. J. Neurochem. 60 (1993) 804-816
18. De Keyser J. Neurochem. Int. 22 (1993) 83-93
19. Seeman P., and Tallerico T. Mol. Psych. 3 (1998) 123-134
20. Coffin V.L., Latranyi M.B., and Chipkin R.E. J. Pharmacol. Exp. Ther. 249 (1989) 769-774
21. Carlsson A., Kehr W., and Lindqvist M. J. Neural. Transm. 39 (1976) 1-19
22. Clark D., Hjorth S., and Carlsson A. J. Neural Transm. 62 (1985) 1-52
23. Clark D., Hjorth S., and Carlsson A. J. Neural Transm. 62 (1985) 171-207
24. Aghajanian G.K., and Bunney B.S. Naunyn-Schmeideberg's Arch. Pharmacol. 297 (1977) 1-7
25. Sokoloff P., Giros B., Matres M.P., Andrieux M., Besancon R., Pilon C., Bouthnet M.L., Souil E., and Schwartz J.C. Arzneim.-Forsch./Drug Res. 42 (1992) 224-230
26. Meller E., Bohmaker K., Goldstein M., and Basham D.A. Eur. J. Pharmacol. 249 (1993) R5-R6
27. Wustrow D.J., and Wise L.D. Curr. Pharm. Res. 3 (1997) 391-404
28. Waters N., Svensson K., Haadsma-Svensson S.R., Smith M.W., and Carlson A. J. Neural Transm. 94 (1993) 11-19
29. Gifford A.N., and Johnson K.M. Eur. J. Pharmacol. 237 (1993) 169-175
30. Svensson K., Carlsson A., and Waters N. J. Neural Transm. 95 (1994)
31. Meador-Woodruff J.H., Mansour A., Bunzow J.R., Van Tol H.H., Watson Jr. S.J., and Civelli O. Proc. Natl. Acad. Sci. USA 86 (1989) 7625-7628
32. Helmreich I., Reimann W., Hertting G., and Starke K. J. Neurosci. 7 (1982) 1559-1566
33. Carlsson A. J. Neural Transm. 57 (1983) 309-315
34. Meller E., Bohmaker K., Namba Y., Friedhoff A.J., and Goldstein M. Mol. Pharmacol. 31 (1987)
35. Meller E., Ena A., and Goldstein M. Eur. J. Pharmacol. 155 (1988) 151-154
36. Carlsson A. In: Carlsson A. (Ed). Dopamine Autoreceptors and Schizophrenia (1988), Cambridge University Press, Cambridge 1-10
37. Creese I., Burt D.R., and Snyder S.H. Science (Washington, DC) 192 (1976) 481-483
38. Pugsley T.A., Christofferson C.L., Corbin A., DeWald H.A., Demattos S., Meltzer L.T., Myers S.L., Shih Y.-H., Whetzel S.Z., Wiley J.N., Wise L.D., and Heffner T.G. J. Pharmacol. Exp. Ther. 263 (1992) 1147-1158
39. Walters J.R., and Roth R.H. Biochem. Pharmacol. 25 (1976) 649-654
40. Walters J.R., and Roth R.H. Naunyn-Schmiedeberg's Arch. Pharmacol. 296 (1976) 5-14
41. Meltzer L.T., Christoffersen C.L., Corbin A.E., Ninteman F.W., Serpa K.A., Wiley J.N., Wise L.D., and Heffner T.G. J. Pharm. Exp. Ther. 274 (1995) 912-920
42. Strombom U. Naunyn-Schmiedeberg's Arch. Pharmacol. 292 (1976) 167-176
43. Martin G.E., and Bendesky R.J. J. Pharmacol. Exp. Ther. 229 (1984) 706-711
44. Svensson L., and Ahlenius S. Eur. J. Pharmacol. 88 (1983) 393-397
45. Liebman J., and Neale R. Psychopharmacol. (Berlin) 68 (1980) 25-29
46. Heffner T.G., Downs D.A., Meltzer L.T., Wiley J.N., and Williams A.E. J. Pharmacol. Exp. Ther. 251 (1989) 105-112
47. Barany S., Ingvast A., and Gunne L.M. Res. Commun. Chem. Pathol. Pharmacol. 25 (1979) 269-279
48. Lehmann J., Briley M., and Langer S. Z. Eur. J. Pharmacol. 88 (1983) 11-26
49. Anden N.E., Nilsson H., Ros E., and Thornstrom U. Acta Pharmacol. Toxicol. Copenh. 52 (1983) 51-56
50. Ericksson E., Svensson K., and Clark D. Life Science (Washington, DC) 36 (1985) 1819-1827
51. Titus R.D., Kornfeld E.C., Jones N.D., Clemens J.A., Smalstig E.B., Fuller R.W., Hahn R.A., Hynes M.D., Mason N.R., Wong D.T., and Foreman M.M. J. Med. Chem. 26 (1983) 1112-1116
52. Hansson L.O., Waters N., Holm S., and Sonesson C. J. Med. Chem. 38 (1995) 3121-3131
53. Metman L.V., Sethy V.H., Roberts J.R., Bravi D., Hoff J.I., Mouradian M.M., and Chase T.N. Mov. Disord. 9 (1994) 577-581
54. Tamminga C.A., Cascella N.G., Lahti R.A., Lindberg M., and Carlsson A. J. Neural. Transm. Gen. Sect. 88 (1992) 165-175
55. Von Voigtlander P.F., Althaus J.S., Ochoa M.C., and Neff G.L. Drug Dev. Res. 17 (1989)
56. Piercey M.F., Broderick P.A., Hoffmann W.E., and Vogelsang G.D. J. Pharmacol. Exp. Ther. 254 (1990) 369-374
57. Jaen J.C. Bioorg. Med. Chem. Lett. 1 (1991) 189-192
58. Benkert O., Muller Siecheneder F., and Wetzel H. Eur. Neuropsychopharmacol. 5 Suppl. (1995) 43-53
59. Coward D.M., Dixon A.K., Urwyler S., White T.G., Enz A., Karobath M., and Shearman G. J. Pharmacol. Exp. Ther. 252 (1990) 279-285
60. Freeman, H.; McDermed, J. D.; Freeman, H.; McDermed, J. D., Ed.; Royal Society of Chemistry: London, 1982.
61. Wikstrom H., Sanchez D., Lindberg P., Hacksell U., Avidsson L.-E., Johansson A.M., Thorberg S.-O., Nilsson J.L., Svensson K., Hjorth S., Clark D., and Carlsson A. J. Med. Chem. 27 (1984) 1030-1036
62. Bottcher H., Barnickel G., Hausberg H.H., Haase A.F., Seyfried C.A., and Eiermann V. J. Med. Chem. 35 (1992) 4020-4026
63. Jaen J.C., Wise L.D., Heffner T.G., Pugsley T.A., and Meltzer L.T. J. Med. Chem. 31 (1988) 1621-1625
64. Breese G.R., and Traylor T.D. J. Pharmacol. Exp. Ther. 174 (1970) 413-420
65. Stricker E.M., and Zigmond M.J. J. Comp. Physiol. Psychol. 86 (1974) 973-994
66. Jaen J.C., Wise L.D., Heffner T.G., Pugsley T.A., and Meltzer L.T. J. Med. Chem. 34 (1991) 248-256
67. Coughenour L.L., McLean J.R., and Parker R.B. Pharmacol. Biochem. Behav. 6 (1977) 351-353
68. Braun A.R., and Chase T.N. Eur. J. Pharmacol. 131 (1986) 301-306
69. Arnt J., Hyttel J., and Perregaard J. Eur. J. Pharmacol. 133 (1987) 137-145
70. Walters J.R., Bergstrom D.A., Carlson J.H., Chase T.N., and Braun A.R. Science (Washington DC) 236 (1987) 719-722
71. Arnt J., Bogeso K.P., Hyttel J., and Meier E. Pharmacol. Toxicol. 62 (1988) 121-130
72. Jaen J.C., Caprathe B.W., Wise L.D., Meltzer L.T., Pugsley T.A., and Heffner T.G. Bioorg. Med. Chem. Lett. 3 (1993) 639-644
73. Wright J.L., Caprathe B.W., Downing D.M., Glase S.A., Heffner T.G., Jaen J.C., Johnson S.J., Kesten S.R., MacKenzie R.G., Meltzer L.T., et al. J. Med. Chem. 37 (1994) 3523-3533
74. Pugsley T.A., Davis M.D., Akunne H.C., Cooke L.W., Whetzel S.Z., MacKenzie R.G., Shih Y.-H., Van Leeuwen D.H., Demattos S.B., Georgic L.M., Caprathe B.W., Wirght J.C., Jaen J.C., Wise L.D., and Heffner T.G. J. Pharm. Exp. Ther. 274 (1995) 898-911
75. De Lean A., Stadel J.M., and Lefkowitz R.J. J. Biol. Chem. 255 (1980) 7108-7117
76. Wright J.L., Downing D.M., Feng M.R., Hayes R.N., Heffner T.G., MacKenzie R.G., Meltzer L.T., Pugsley T.A., and Wise L.D. J. Med. Chem. 38 (1995) 5007-5014
77. Wise L.D., Jaen J.C., Caprathe B.W., Smith S.J., Pugsley T.A., and Heffner T.G. Soc. Neurosci. Abs. 17 (1991) 689
78. Wustrow D.J., Wise L.D., Cody D.M., MacKenzie R.G., Georgic L.M., Pugsley T.A., and Heffner T.G. J. Med. Chem. 37 (1994) 4251-4257
79. O'Hara C., Uhland Smith A., KL O.M., and Todd R.D. J. Pharmacol. Exp. Ther. 277 (1996) 186-192
80. Tang L., Todd R.D., and KL O.M. J. Pharmacol. Exp. Ther. 270 (1994) 475-479
81. Belliotti T.R., Kesten S.R., Rubin J.R., Wustrow D.J., Georgic L.M., Zoski K.T., Akunne H.C., and Wise L.D. Bioorg. Med. Chem. Lett. 7 (1997) 2403-2408
82. Wustrow D.J., W.J.I. S., Corbin A.E., Davis M.D., Georgic L.M., Pugsley T.A., Whetzel S.Z., Heffner T.G., and Wise L.D. J. Med. Chem. 40 (1997) 250-259
83. Glase S.A., Akunne H.C., Heffner T.G., Jaen J.C., MacKenzie R.G., Meltzer L.T., Pugsley T.A., Smith S.J., and Wise L.D. J. Med. Chem. 39 (1996) 3179-3187
84. Wetzel H., Hillert A., Grunder G., and Benkert O. Am. J. Psychiatry 151 (1994) 1499-1502
85. Wustrow D., Belliotti T., Glase S., Kesten S.R., Johnson D., Colbry N., Rubin R., Blackburn A., Akunne H., Corbin A., Davis M.D., Georgic L., Whetzel S., Zoski K., Heffner T., Pugsley T., and Wise L. J. Med. Chem. 41 (1998) 760-771
86. McMillen B.A., Scott S.M., and Davanzo E.A. J. Pharm. Pharmacol. 40 (1988) 885-887
87. Invernizzi R.W., Cervo L., and Samanin R. Neuropharmacology 27 (1988) 515-518
88. Neal Beliveau B.S., Joyce J.N., and Lucki I. J. Pharmacol. Exp. Ther. 265 (1993) 207-217
89. Wadenberg M.L., Cortizo L., and Ahlenius S. Pharmacol. Biochem. Behav. 47 (1994) 509-513